Clinical Trial Update: A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetic Profiles of Multiple Doses of ABT-072 Used to Treat Hepatitis C [Phase 1]

View source ↗

Summary

This Phase 1 study in healthy adults evaluated the safety, tolerability, and pharmacokinetics of multiple doses of ABT-072 for hepatitis C, and the trial has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• ABT-072

Snippet

Sponsor: Abbott | Conditions: HCV Infection | Phase 1 | Status: COMPLETED